The global women's health diagnostics market size reached US$ 29.2 Billion in 2023. Looking forward, the market is projected to reach US$ 52.6 Billion by 2032, exhibiting a growth rate (CAGR) of 6.76% during 2023-2032.
Women's health diagnostics help diagnose various biological and psychosocial conditions of female patients. They assist in addressing sexual and vaginal issues and pregnancy complications and managing threatening diseases, such as osteoporosis, menopause, and certain cancers like breast and cervical. They rely on a series of advanced laboratory tests, tools, and procedures, which include biopsy, ultrasound, chemotherapy, and magnetic resonance imaging (MRI). Several healthcare diagnostics centers are currently offering an expansive range of laboratory testing solutions to enhance the diagnosis and management of rare diseases and conditions that affect women.
Furthermore, as menopause can increase the risk of developing certain medical conditions, including cardiovascular diseases and urinary incontinence, a significant rise in the female population which is over 50 years is contributing to the market growth. Besides this, several research studies have concluded that women are more likely to experience psychiatric disorders, such as depression and anxiety, during hormonal changes. This, in confluence with several initiatives undertaken by health agencies of numerous countries to improve mental health of women, is propelling the market growth across the globe.
2. What is the expected growth rate of the global women’s health diagnostics market during 2024-2032?
3. What are the key factors driving the global women’s health diagnostics market?
4. What has been the impact of COVID-19 on the global women’s health diagnostics market?
5. What is the breakup of the global women’s health diagnostics market based on the type?
6. What is the breakup of the global women’s health diagnostics market based on the application?
7. What is the breakup of the global women’s health diagnostics market based on the end user?
8. What are the key regions in the global women’s health diagnostics market?
9. Who are the key players/companies in the global women’s health diagnostics market?
Women's health diagnostics help diagnose various biological and psychosocial conditions of female patients. They assist in addressing sexual and vaginal issues and pregnancy complications and managing threatening diseases, such as osteoporosis, menopause, and certain cancers like breast and cervical. They rely on a series of advanced laboratory tests, tools, and procedures, which include biopsy, ultrasound, chemotherapy, and magnetic resonance imaging (MRI). Several healthcare diagnostics centers are currently offering an expansive range of laboratory testing solutions to enhance the diagnosis and management of rare diseases and conditions that affect women.
Women's Health Diagnostics Market Trends
The rising prevalence of health issues that impact the overall well-being of women represents one of the major factors influencing the market positively. Moreover, the growing health consciousness, along with the increasing awareness about the benefits of early diagnosis, is catalyzing the demand for point-of-care (POC) women’s health diagnostics across the globe. Apart from this, the rising rate of infertility on account of stressful lifestyles and the growing consumption of alcohol and drugs is driving the need for women’s health diagnostics to address pregnancy complications and ensure a healthier life.Furthermore, as menopause can increase the risk of developing certain medical conditions, including cardiovascular diseases and urinary incontinence, a significant rise in the female population which is over 50 years is contributing to the market growth. Besides this, several research studies have concluded that women are more likely to experience psychiatric disorders, such as depression and anxiety, during hormonal changes. This, in confluence with several initiatives undertaken by health agencies of numerous countries to improve mental health of women, is propelling the market growth across the globe.
Key Market Segmentation
This report provides an analysis of the key trends in each sub-segment of the global women's health diagnostics market report, along with forecasts at the global, regional and country level from 2024-2032. The report has categorized the market based on type, application, and end user.Breakup by Type:
- Diagnostic Devices
- Biopsy Device
- Imaging and Monitoring Devices
- Accessories and Consumables
- Diagnostic Tests
- Breast Cancer Testing
- PAP Smear and HPV Test
- Pregnancy Testing and Ovulation Testing
- Others
Breakup by Application:
- Breast Cancer
- Infectious Disease Testing
- Osteoporosis Testing
- Pregnancy and Fertility Testing
- Sexually Transmitted Disease Testing
- Others
Breakup by End User:
- Hospital and Diagnostics Centers
- Home Care
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, bioMérieux SA, Cardinal Health Inc., Cook Group Incorporated, F. Hoffmann-La Roche AG, General Electric Company, Hologic Inc., Koninklijke Philips N.V., Perkinelmer Inc., Quest Diagnostics Inc., Siemens AG and Thermo Fisher Scientific Inc.Key Questions Answered in This Report
1. What was the size of the global women’s health diagnostics market in 2023?2. What is the expected growth rate of the global women’s health diagnostics market during 2024-2032?
3. What are the key factors driving the global women’s health diagnostics market?
4. What has been the impact of COVID-19 on the global women’s health diagnostics market?
5. What is the breakup of the global women’s health diagnostics market based on the type?
6. What is the breakup of the global women’s health diagnostics market based on the application?
7. What is the breakup of the global women’s health diagnostics market based on the end user?
8. What are the key regions in the global women’s health diagnostics market?
9. Who are the key players/companies in the global women’s health diagnostics market?
Table of Contents
1 Preface3 Executive Summary11 Value Chain Analysis13 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Women's Health Diagnostics Market
6 Market Breakup by Type
7 Market Breakup by Application
8 Market Breakup by End User
9 Market Breakup by Region
10 SWOT Analysis
12 Porters Five Forces Analysis
14 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Abbott Laboratories
- Becton Dickinson and Company
- bioMérieux SA
- Cardinal Health Inc.
- Cook Group Incorporated
- F. Hoffmann-La Roche AG
- General Electric Company
- Hologic Inc.
- Koninklijke Philips N.V.
- Perkinelmer Inc.
- Quest Diagnostics Inc.
- Siemens AG
- Thermo Fisher Scientific Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 138 |
| Published | April 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 29.2 Billion |
| Forecasted Market Value ( USD | $ 52.6 Billion |
| Compound Annual Growth Rate | 6.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 13 |
